These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36264321)

  • 21. Vaccine safety - is the SARS-CoV-2 vaccine any different?
    Tau N; Yahav D; Shepshelovich D
    Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [COVID-19 vaccine safety].
    Chaparro Mérida NA; Moreno Samper D; Lacato AOF
    Rev Peru Med Exp Salud Publica; 2021; 38(4):634-642. PubMed ID: 35385018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut].
    May S; Kaul S; Schröder C; Vieths S
    Hautarzt; 2006 Oct; 57(10):867-74. PubMed ID: 16977441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality Control of Immunological Veterinary Medicinal Products in Europe.
    Pasik K; Łysiak E
    J Vet Res; 2019 Dec; 63(4):587-595. PubMed ID: 31934671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines.
    Ambrosino D; Han HH; Hu B; Liang J; Clemens R; Johnson M; Siber G; Goldblatt D
    J Infect Dis; 2022 Jan; 225(2):327-331. PubMed ID: 34888662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making sense of unfamiliar COVID-19 vaccines: How national origin affects vaccination willingness.
    Jensen EA; Wagoner B; Pfleger A; Herbig L; Watzlawik M
    PLoS One; 2021; 16(12):e0261273. PubMed ID: 34965278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 pandemic predictions using the modified Bateman SIZ model and observational data for Heidelberg, Germany: Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App.
    Braun P; Haffner S; Woodcock BG
    Int J Clin Pharmacol Ther; 2020 Aug; 58(8):417-425. PubMed ID: 32646540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID vaccine recommendations in dermatologic patients on immunosuppressive agents: Lessons learned from pandemic.
    Aryanian Z; Balighi K; Afshar ZM; Zamanian MH; Razavi Z; Hatami P
    J Cosmet Dermatol; 2022 Dec; 21(12):6568-6573. PubMed ID: 36214611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Points to consider for COVID-19 vaccine quality control and national lot release in Republic of Korea: focus on a viral vector platform.
    Ju JH; Lee N; Kim SH; Chang S; Yang M; Shin J; Lee E; Sung S; Kim JH; Hong JT; Oh HJ
    Osong Public Health Res Perspect; 2022 Feb; 13(1):4-14. PubMed ID: 35255674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Governmental batch sample testing of allergen products].
    Bartel D; Führer F; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):358-62. PubMed ID: 22373849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Instruments of official communication by regulatory authorities on risks of drug use].
    Bergner S; Grüger T; Huber M; Lütkehermölle W; Paeschke N; Palissa H; Stephan K; Cibura S; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 May; 65(5):567-576. PubMed ID: 35471605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a Pandemic.
    Sherman AC; Rouphael N; Baden LR
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S5-S10. PubMed ID: 35436331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Bench Side to Bed-Travelling on a Road to Get a Safe and Effective Vaccine against COVID-19, Day to Save the Life.
    Ray SK; Mukherjee S
    Recent Pat Biotechnol; 2022; 16(1):2-5. PubMed ID: 34886784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vaccination contre le SARS-CoV-2, le Graal ?].
    Binh Luong Nguyen L; Lachâtre M; Launay O
    Rev Prat; 2022 May; 72(5):517-522. PubMed ID: 35899638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Vaccines: Preparing for Vaccination in the Context of Clinical Oncology Care.
    Carr E
    Clin J Oncol Nurs; 2021 Feb; 25(1):76-84. PubMed ID: 33480870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-sectional study of the knowledge, perception and attitude of first-year university students in Iraq towards SARS-CoV-2 Omicron variant and COVID-19 vaccines.
    Abed M; Al Omari S; Mourad R; Al Faraj A
    BMJ Open; 2022 Nov; 12(11):e064301. PubMed ID: 36410839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief review of the mRNA vaccines COVID-19.
    Vitiello A; Ferrara F
    Inflammopharmacology; 2021 Jun; 29(3):645-649. PubMed ID: 33932192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What impact does the attitude toward COVID-19 vaccination have on physicians as vaccine providers? A cross sectional study from the German outpatient sector.
    Stöcker A; Hoffmann J; Mause L; Neufeind J; Ohnhäuser T; Scholten N
    Vaccine; 2023 Jan; 41(1):263-273. PubMed ID: 36456389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.
    Aripov T; Wikler D; Asadov D; Tulekov Z; Murzabekova T; Munir KM
    BMC Med Ethics; 2022 Mar; 23(1):21. PubMed ID: 35264173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.